Andreas Halvorsen: portfolio of Viking Global Investors

Andreas Halvorsen leads Viking Global Investors, a hedge fund that analyzes stocks worldwide and combines long and short positions.

Source: 13F filing with the US Securities and Exchange Commission dated Aug 14, 2026. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included.

You are looking at Q2 2026. Go to the latest filing (Q3 2026)

35.1B USDQ2 2026
Total value of stock positions
35.1B USD
Positions
90
Share of the ten largest
35.7%

The ten largest positions Q2 2026

  1. Visa Inc. 6.3%▲ +1.0%
  2. Taiwan Semiconductor Manufacturing (ADR) 4.3%▼ −29.0%
  3. Air Products 4.0%▲ +15.5%
  4. Sherwin-Williams 3.8%▲ +24.5%
  5. Fortive 3.5%▼ −11.3%
  6. Meta Platforms 3.0%▲ +75.8%
  7. Charles Schwab Corporation 2.8%▼ −27.5%
  8. Thermo Fisher Scientific 2.8%▲ +16.2%
  9. JPMorgan Chase 2.7%▲ +7.2%
  10. Lennox International 2.6%▲ +1.2%
Total value of stock positions per quarter, Q2 2013 to Q3 2026 (peak 38.5B USD).
Choose a quarter (54 filings)

All positions Q2 2026

Positions Q2 2026 per 13F filing, 90 of 90
Symbol Weight Shares Reported value Change Held since
V Visa Inc. 6.3% 6,393,604 2.2B USD +1.0% increased Q3 2024 8 quarters
TSM Taiwan Semiconductor Manufacturing (ADR) 4.3% 3,168,097 1.5B USD −29.0% reduced Q4 2024 7 quarters
APD Air Products 4.0% 4,740,351 1.4B USD +15.5% increased Q2 2025 5 quarters
SHW Sherwin-Williams 3.8% 3,875,879 1.3B USD +24.5% increased Q2 2024 9 quarters
FTV Fortive 3.5% 19,934,762 1.2B USD −11.3% reduced Q3 2019 28 quarters
META Meta Platforms 3.0% 1,867,619 1.1B USD +75.8% increased Q1 2026 2 quarters
SCHW Charles Schwab Corporation 2.8% 10,638,869 981.6M USD −27.5% reduced Q3 2024 8 quarters
TMO Thermo Fisher Scientific 2.8% 1,937,415 971.3M USD +16.2% increased Q4 2025 3 quarters
JPM JPMorgan Chase 2.7% 2,899,386 949.1M USD +7.2% increased Q2 2024 9 quarters
LII Lennox International 2.6% 1,590,959 911.5M USD +1.2% increased Q4 2025 3 quarters
AMZN Amazon 2.5% 3,700,862 882.1M USD +209.6% increased Q4 2025 3 quarters
Ferrari N V 2.3% 2,204,309 816.9M USD new Q2 2026 1 quarter
CVNA Carvana 2.3% 12,322,311 811.1M USD −11.4% reducedafter 5:1 stock split Q2 2024 9 quarters
Mcdonalds Corp 2.2% 2,829,158 764.7M USD −22.0% reduced Q1 2025 6 quarters
Bridgebio Pharma Inc 2.1% 9,949,219 741.0M USD −16.0% reduced Q2 2019 29 quarters
BA Boeing 2.0% 3,274,825 708.9M USD +2.5% increased Q4 2024 7 quarters
MAA Mid-America Apartment Communities 2.0% 5,043,318 700.7M USD +5.1% increased Q3 2025 4 quarters
DIS Walt Disney Company (The) 2.0% 7,158,406 689.0M USD −46.2% reduced Q2 2025 5 quarters
FDX FedEx 1.9% 2,151,983 673.9M USD +11.4% increased Q1 2026 2 quarters
MSCI MSCI 1.9% 1,160,687 650.0M USD new Q2 2026 1 quarter
Adaptive Biotechnologies Cor 1.8% 29,993,708 643.4M USD unchanged Q2 2019 29 quarters
WAT Waters Corporation 1.8% 1,662,140 623.4M USD +32.3% increased Q1 2026 2 quarters
JCI Johnson Controls 1.8% 4,202,694 614.1M USD −4.9% reduced Q2 2025 5 quarters
UNP Union Pacific Corporation 1.6% 2,047,332 556.9M USD new Q2 2026 1 quarter
MSFT Microsoft 1.6% 1,458,618 544.1M USD −36.8% reduced Q3 2025 4 quarters
SE Sea Limited (ADR) 1.5% 5,669,877 543.3M USD +19.7% increased Q1 2025 6 quarters
CPT Camden Property Trust 1.5% 4,513,303 516.7M USD −4.3% reduced Q1 2024 10 quarters
Regal Rexnord Corporation 1.4% 2,101,759 500.6M USD −33.1% reduced Q4 2023 11 quarters
Biomarin Pharmaceutical Inc 1.2% 7,616,563 435.8M USD +7.9% increased Q4 2021 19 quarters
IBKR Interactive Brokers 1.2% 4,830,748 420.5M USD +246.5% increased Q1 2026 2 quarters
DLR Digital Realty 1.2% 2,310,475 414.9M USD new Q2 2026 1 quarter
CCL Carnival Corporation 1.2% 14,299,953 408.5M USD +4.2% increased Q4 2025 3 quarters
GM General Motors 1.1% 5,005,833 385.8M USD −45.5% reduced Q4 2024 7 quarters
AON Aon plc 1.1% 1,151,269 381.9M USD +5.9% increased Q3 2025 4 quarters
CVS CVS Health 1.1% 3,663,361 379.0M USD new Q2 2026 1 quarter
Fedex Fght Hldg Co Inc 1.0% 2,366,634 357.4M USD new Q2 2026 1 quarter
ICE Intercontinental Exchange 1.0% 2,777,138 341.9M USD −42.6% reduced Q4 2025 3 quarters
MS Morgan Stanley 1.0% 1,622,593 339.2M USD new Q2 2026 1 quarter
HD Home Depot (The) 0.9% 920,595 324.7M USD +82.6% increased Q1 2026 2 quarters
Tic Solutions Inc 0.8% 35,824,562 289.8M USD unchanged Q1 2025 6 quarters
QCOM Qualcomm 0.8% 1,514,185 279.8M USD new Q2 2026 1 quarter
APTV Aptiv 0.8% 4,552,887 279.5M USD new Q2 2026 1 quarter
RDDT Reddit 0.8% 1,565,518 271.7M USD −38.6% reduced Q1 2026 2 quarters
HAS Hasbro 0.7% 3,107,195 256.6M USD −16.9% reduced Q1 2026 2 quarters
Avalonbay Cmntys Inc 0.7% 1,339,782 252.8M USD new Q2 2026 1 quarter
Dicks Sporting Goods Inc 0.7% 1,106,134 250.9M USD −12.5% reduced Q4 2025 3 quarters
SNOW Snowflake 0.7% 960,138 244.4M USD new Q2 2026 1 quarter
Equitable HLDGS Inc 0.7% 5,398,896 236.9M USD new Q2 2026 1 quarter
TTWO Take-Two Interactive 0.7% 940,605 235.1M USD new Q2 2026 1 quarter
TSLA Tesla, Inc. 0.7% 547,816 230.4M USD −78.0% reduced Q1 2025 6 quarters
Ati Inc 0.6% 1,153,880 227.4M USD −65.4% reduced Q1 2026 2 quarters
Roivant Sciences Ltd 0.6% 6,271,467 221.9M USD −5.7% reduced Q4 2021 19 quarters
SPCX Space Exploration Technologies (Class A) 0.6% 1,200,000 205.0M USD new Q2 2026 1 quarter
Amer Sports Inc 0.6% 5,954,351 201.5M USD −18.1% reduced Q1 2025 6 quarters
Veradermics Inc 0.5% 1,561,494 192.0M USD −7.6% reduced Q1 2026 2 quarters
Medline Inc 0.5% 4,841,080 190.9M USD −57.7% reduced Q4 2025 3 quarters
Bce Inc 0.5% 8,383,278 180.6M USD new Q2 2026 1 quarter
US Foods Hldg Corp 0.5% 1,734,346 177.3M USD new Q2 2026 1 quarter
Oruka Therapeutics Inc 0.4% 1,503,478 143.1M USD – Q3 2025 4 quarters
Newamsterdam Pharma Company 0.4% 4,203,567 142.5M USD unchanged Q4 2022 15 quarters
Sionna Therapeutics Inc 0.4% 3,195,181 140.6M USD unchanged Q1 2025 6 quarters
CB Chubb Limited 0.4% 377,312 128.6M USD −70.9% reduced Q4 2025 3 quarters
Pharvaris N V 0.4% 3,653,310 126.3M USD unchanged Q1 2021 22 quarters
UBS Group AG 0.3% 2,435,805 120.8M USD new Q2 2026 1 quarter
Brightspring Health Svcs Inc 0.3% 1,618,237 112.9M USD new Q2 2026 1 quarter
Inhibrx Biosciences Inc 0.3% 1,123,929 106.5M USD −21.8% reduced Q2 2024 9 quarters
Natera Inc 0.3% 390,694 106.1M USD new Q2 2026 1 quarter
Deutsche Bk AG 0.2% 2,510,554 85.0M USD new Q2 2026 1 quarter
COF Capital One 0.2% 387,815 77.8M USD −75.9% reduced Q1 2025 6 quarters
Corebridge Finl Inc 0.2% 2,679,371 76.7M USD new Q2 2026 1 quarter
Solaredge Technologies Inc 0.2% 1,088,469 63.6M USD new Q2 2026 1 quarter
Damora Therapeutics Inc 0.2% 2,311,082 60.1M USD unchanged Q1 2026 2 quarters
Oric Pharmaceuticals Inc 0.2% 5,126,762 55.5M USD −12.0% reduced Q1 2024 10 quarters
Bruker Corp 0.2% 893,491 53.8M USD new Q2 2026 1 quarter
Standard Biotools Inc 0.1% 58,651,170 48.3M USD unchanged Q1 2024 10 quarters
Ginkgo Bioworks Holdings Inc 0.1% 3,577,128 35.4M USD unchanged Q3 2024 8 quarters
CME CME Group < 0.1% 152,980 33.8M USD new Q2 2026 1 quarter
Tradeweb Mkts Inc < 0.1% 314,222 31.3M USD new Q2 2026 1 quarter
Trevi Therapeutics Inc < 0.1% 1,544,644 28.8M USD −51.7% reduced Q3 2022 16 quarters
Infleqtion Inc < 0.1% 2,032,649 27.1M USD new Q2 2026 1 quarter
Artiva Biotherapeutics Inc < 0.1% 2,604,166 25.3M USD new Q2 2026 1 quarter
Quantinuum Inc < 0.1% 306,123 25.0M USD new Q2 2026 1 quarter
Fervo Energy Co < 0.1% 750,000 21.9M USD new Q2 2026 1 quarter
Altimmune Inc < 0.1% 6,700,000 20.4M USD new Q2 2026 1 quarter
Toll Brothers Inc < 0.1% 109,856 18.1M USD new Q2 2026 1 quarter
Dpc Holdings PLC < 0.1% 306,123 15.0M USD new Q2 2026 1 quarter
X-Energy Inc < 0.1% 714,286 13.1M USD new Q2 2026 1 quarter
Azul S A < 0.1% 1,349,734 12.1M USD new Q2 2026 1 quarter
Rallybio Corp < 0.1% 524,347 8.4M USD unchanged Q1 2026 2 quarters
Pepgen Inc < 0.1% 3,482,434 6.3M USD unchanged Q2 2022 17 quarters

“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.

Breakdown by sector

  • Financials 18.5%
  • Industrials 13.3%
  • Consumer Discretionary 10.2%
  • Materials 7.8%
  • Technology 7.4%
  • Communication Services 6.4%
  • Health Care 5.6%
  • Real Estate 4.7%
  • not in our coverage 26.1%

Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.

How to read this page

  • Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
  • Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
  • Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.

All superinvestor portfolios Screener: stocks held by superinvestors

↑ ↓ select · Enter open · Esc close